[
  {
    "ts": "2026-01-07T12:48:23+00:00",
    "headline": "Merck Begins Phase 3 Trial of Calderasib With Keytruda QLEX in Non-Small Cell Lung Cancer",
    "summary": "Merck (MRK) said Wednesday it has initiated a phase 3 clinical trial to evaluate calderasib combined",
    "url": "https://finance.yahoo.com/news/merck-begins-phase-3-trial-124823216.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "15004991-c4ba-3059-bae4-831ea3a4ff23",
      "content": {
        "id": "15004991-c4ba-3059-bae4-831ea3a4ff23",
        "contentType": "STORY",
        "title": "Merck Begins Phase 3 Trial of Calderasib With Keytruda QLEX in Non-Small Cell Lung Cancer",
        "description": "",
        "summary": "Merck (MRK) said Wednesday it has initiated a phase 3 clinical trial to evaluate calderasib combined",
        "pubDate": "2026-01-07T12:48:23Z",
        "displayTime": "2026-01-07T12:48:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-begins-phase-3-trial-124823216.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-begins-phase-3-trial-124823216.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:50:00+00:00",
    "headline": "Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC",
    "summary": "RAHWAY, N.J., January 07, 2026--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a Phase 3 clinical trial evaluating calderasib (MK-1084), an investigational oral selective KRAS G12C inhibitor, in combination with KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) for the first-line treatment of patients with KRAS G12C-mutant, advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC).",
    "url": "https://finance.yahoo.com/news/merck-initiates-phase-3-kandlelit-115000422.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b532d15e-bc48-331b-a970-e9c8ca83f074",
      "content": {
        "id": "b532d15e-bc48-331b-a970-e9c8ca83f074",
        "contentType": "STORY",
        "title": "Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC",
        "description": "",
        "summary": "RAHWAY, N.J., January 07, 2026--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a Phase 3 clinical trial evaluating calderasib (MK-1084), an investigational oral selective KRAS G12C inhibitor, in combination with KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) for the first-line treatment of patients with KRAS G12C-mutant, advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC).",
        "pubDate": "2026-01-07T11:50:00Z",
        "displayTime": "2026-01-07T11:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/17aa6c5d82094f902222cb82a9850432",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0hcRKnAvle_1UGXmzCIB3Q--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/17aa6c5d82094f902222cb82a9850432.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7ndZCJRGLrHJn5Vh0EMawg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/17aa6c5d82094f902222cb82a9850432.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-initiates-phase-3-kandlelit-115000422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-initiates-phase-3-kandlelit-115000422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:45:00+00:00",
    "headline": "Merck to Complete Acquisition of Cidara Therapeutics",
    "summary": "RAHWAY, N.J., January 07, 2026--Merck to Complete Acquisition of Cidara Therapeutics",
    "url": "https://finance.yahoo.com/news/merck-complete-acquisition-cidara-therapeutics-114500819.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8fb794a8-36b0-3311-bc24-76f847d0e428",
      "content": {
        "id": "8fb794a8-36b0-3311-bc24-76f847d0e428",
        "contentType": "STORY",
        "title": "Merck to Complete Acquisition of Cidara Therapeutics",
        "description": "",
        "summary": "RAHWAY, N.J., January 07, 2026--Merck to Complete Acquisition of Cidara Therapeutics",
        "pubDate": "2026-01-07T11:45:00Z",
        "displayTime": "2026-01-07T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/bcf4baf8584f1d548ba01176a4b5786a",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hyeFI2lrYDdgM.6Tm5YIHw--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bcf4baf8584f1d548ba01176a4b5786a.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sCLlrDUqCc56U.PHk4_1NA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bcf4baf8584f1d548ba01176a4b5786a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-complete-acquisition-cidara-therapeutics-114500819.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-complete-acquisition-cidara-therapeutics-114500819.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:30:00+00:00",
    "headline": "Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3",
    "summary": "RAHWAY, N.J., January 07, 2026--Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3",
    "url": "https://finance.yahoo.com/news/merck-hold-fourth-quarter-full-113000481.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ba615939-0a9f-32c9-98f1-e2107fa2de6e",
      "content": {
        "id": "ba615939-0a9f-32c9-98f1-e2107fa2de6e",
        "contentType": "STORY",
        "title": "Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3",
        "description": "",
        "summary": "RAHWAY, N.J., January 07, 2026--Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3",
        "pubDate": "2026-01-07T11:30:00Z",
        "displayTime": "2026-01-07T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f9d602a92c904f1c427cc2d95fd9e343",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l9IrnS_NXYg3IDvtq8rP3Q--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9d602a92c904f1c427cc2d95fd9e343.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/of7TiqCVpapzxsoTyQr4ow--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9d602a92c904f1c427cc2d95fd9e343.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-hold-fourth-quarter-full-113000481.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-hold-fourth-quarter-full-113000481.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:20:14+00:00",
    "headline": "Bank of America Out With Q1 2026 Top US Ideas Dividend Picks",
    "summary": "These top BofA Securities stock picks are perfect for growth and income investors seeking dependable passive income from reliable companies.",
    "url": "https://247wallst.com/investing/2026/01/07/bank-of-america-out-with-q1-2026-top-u-s-ideas-dividend-picks/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "332655c8-06a8-3588-b8de-99798002f7df",
      "content": {
        "id": "332655c8-06a8-3588-b8de-99798002f7df",
        "contentType": "STORY",
        "title": "Bank of America Out With Q1 2026 Top US Ideas Dividend Picks",
        "description": "",
        "summary": "These top BofA Securities stock picks are perfect for growth and income investors seeking dependable passive income from reliable companies.",
        "pubDate": "2026-01-07T13:20:14Z",
        "displayTime": "2026-01-07T13:20:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/d6ce401462337988dbf44693432dd993",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7BzdA6vic4qcxCb._cqZLg--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/d6ce401462337988dbf44693432dd993.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j5mJSYqVy7Tr4P9Xf4ev.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/d6ce401462337988dbf44693432dd993.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/01/07/bank-of-america-out-with-q1-2026-top-u-s-ideas-dividend-picks/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bank-america-q1-2026-top-132014288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAC"
            },
            {
              "symbol": "DG"
            },
            {
              "symbol": "EQIX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "CI"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T14:00:05+00:00",
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140005659.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "121b8297-7c4b-3f08-9bc7-cf41b8c2077c",
      "content": {
        "id": "121b8297-7c4b-3f08-9bc7-cf41b8c2077c",
        "contentType": "STORY",
        "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
        "description": "",
        "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
        "pubDate": "2026-01-07T14:00:05Z",
        "displayTime": "2026-01-07T14:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be",
          "originalWidth": 900,
          "originalHeight": 594,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jcpSnlhnuuUas5U.67zBPQ--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be.cf.webp",
              "width": 900,
              "height": 594,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk1JxpBvTuD8ecx2ZnLlEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140005659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140005659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T16:34:00+00:00",
    "headline": "The Dow Is Cruising Past Milestones. What Comes After 50,000.",
    "summary": "The Dow Jones Industrial Average is on the verge of another big milestone and could continue to climb as the rally broadens.",
    "url": "https://www.barrons.com/articles/dow-50k-stocks-rally-cecd3771?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "02128e1c-c43c-3286-938a-9814ecb4923e",
      "content": {
        "id": "02128e1c-c43c-3286-938a-9814ecb4923e",
        "contentType": "STORY",
        "title": "The Dow Is Cruising Past Milestones. What Comes After 50,000.",
        "description": "",
        "summary": "The Dow Jones Industrial Average is on the verge of another big milestone and could continue to climb as the rally broadens.",
        "pubDate": "2026-01-07T16:34:00Z",
        "displayTime": "2026-01-07T16:34:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/02128e1c-c43c-3286-938a-9814ecb4923e/the-dow-is-cruising-past.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5bebe976fdc660bb6e5dfa4e05f0a39d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hZnuxEixFvVWVRrPOjVfRQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5bebe976fdc660bb6e5dfa4e05f0a39d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GQ90KaVHpXRatLijk7bmJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5bebe976fdc660bb6e5dfa4e05f0a39d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/dow-50k-stocks-rally-cecd3771?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]